Basics Alumis Inc. Common Stock IPO Date: June 28, 2024 Sector: Healthcare Industry: Biotech Market Cap: $495.35M Activated in VL: True Average Daily Range Avg Daily Range: $0.30 | 4.24% Avg Daily Range (30 D): $0.10 | 2.27% Avg Daily Range (90 D): $0.11 | 2.73% Institutional Daily Volume Avg Daily Volume: .4M Avg Daily Volume (30 D): .52M Avg Daily Volume (90 D): .6M Trade Size Avg Trade Size (Sh.): 88 Avg Trade Size (Sh.) (30 D): 87 Avg Trade Size (Sh.) (90 D): 102 Institutional Trades Total Inst.Trades: 37 Avg Inst. Trade: $1.84M Avg Inst. Trade (30 D): $1.56M Avg Inst. Trade (90 D): $1.32M Avg Inst. Trade Volume: .25M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.96M Avg Closing Trade (30 D): $4.35M Avg Closing Trade (90 D): $1.91M Avg Closing Volume: 402.7K     News Oct 16, 2025 @ 5:00 PM Thyroid Eye Disease Clinical Trial Pipeline Gains ... Source: Delveinsight Aug 13, 2025 @ 8:28 PM Alumis Misses Q2 Revenue as Costs Jump Source: Na May 21, 2025 @ 1:10 PM Alumis Completes Merger with ACELYRIN Source: Globe Newswire May 13, 2025 @ 5:00 PM Alumis Stockholders Approve Merger with ACELYRIN Source: N/A May 13, 2025 @ 5:00 PM ACELYRIN Stockholders Approve Merger with Alumis t... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-26.88 $-1.82 $-.23 Diluted EPS $-26.88 $-1.82 $-.23 Revenue $ 17.39M $ 17.39M $ M Gross Profit $ $ $ Net Income / Loss $ -343.35M $ -98.96M $ -94.76M Operating Income / Loss $ -354.69M $ -101.53M $ -98.62M Cost of Revenue $ $ $ Net Cash Flow $ 57.42M $ M $ -43.81M PE Ratio